Advertisement

Helicobacter pylori infection associated with type 2 diabetic nephropathy in patients with dyspeptic symptoms

Published:September 18, 2015DOI:https://doi.org/10.1016/j.diabres.2015.09.008

      Highlights

      • The association of H. pylori infection and diabetic nephropathy was studied.
      • H. pylori infection is associated with increased proteinuria in diabetics.
      • Patients with diabetic nephropathy are at high risk for infection by H. pylori.
      • High levels of TNF-α and IL-8 are detected in H. pylori + diabetics.
      • Gastroduodenal lesions do not associated with diabetic nephropathy.

      Abstract

      Aims

      The aim of this conventional case–control study was to investigate the prevalence and relationship between Helicobacter pylori infection in type 2 diabetes mellitus (DM) and diabetic nephropathy (DN).

      Methods

      A total of 241 type 2 DM patients and 69 non-diabetic subjects with dyspeptic symptoms were enrolled in the study. Gastroduodenal lesions were observed by gastrointestinal endoscopy and the presence of H. pylori was identified by rapid urease test and serum IgG antibodies to H. pylori. According to the urinary albumin excretion rate (UAE), patients were classified into diabetes mellitus group (DM group, with UAE <30 mg/24 h); diabetic nephropathy group 1 (DN group 1, with UAE 30 mg/24 h to <300 mg/24 h); and diabetic nephropathy group 2 (DN group 2 ≥ 300 mg/24 h). The 69 non-diabetic subjects were used as control group. The serum levels of inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin (IL)-8 were determined using ELISA.

      Results

      The prevalence of H. pylori infection in DN group 1 and DN group 2 was 45/72 (62.5%) and 34/53 (64.15%), respectively, which was significantly higher than in control [28/65 (43.1%)] and DM groups [42.9% (27/63)]. No significant differences of H. pylori prevalence were detected between DN groups as well as DM and control groups. Interestingly, in both DN groups, higher levels of IL-8, TNF-α and urinary albumin excretion rate were found in H. pylori positive subjects.

      Conclusions

      Diabetic nephropathy patients are more susceptible to H. pylori infection. Our data support an association between H. pylori infection and diabetic nephropathy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bener A.
        • Uduman S.A.
        • Ameen A.
        • Alwash R.
        • Pasha M.A.
        • Usmani M.A.
        • et al.
        Prevalence of Helicobacter pylori infection among low socio-economic workers.
        J Commun Dis. 2002; 34: 179-184
        • Franceschi F.
        • Tortora A.
        • Gasbarrini G.
        • Gasbarrini A.
        Helicobacter pylori and extragastric diseases.
        Helicobacter. 2014; 19: 52-58
        • Vafaeimanesh J.
        • Hejazi S.F.
        • Damanpak V.
        • Vahedian M.
        • Sattari M.
        • Seyyedmajidi M.
        Association of Helicobacter pylori infection with coronary artery disease: is Helicobacter pylori a risk factor?. 2014; : 516354
        • Wada T.
        • Shimizu M.
        • Toyama T.
        • Hara A.
        • Kaneko S.
        • Furuichi K.
        Clinical impact of albuminuria in diabetic nephropathy.
        Clin Exp Nephrol. 2012; 16: 96-101
        • Chadban S.
        • Howell M.
        • Twigg S.
        • Thomas M.
        • Jerums G.
        • Cass A.
        • et al.
        The CARI guidelines. Assessment of kidney function in type 2 diabetes.
        Nephrology (Carlton, Vic). 2010; 15: S146-S161
        • King G.L.
        The role of inflammatory cytokines in diabetes and its complications.
        J Periodontol. 2008; 79: 1527-1534
        • Lutsey P.L.
        • Pankow J.S.
        • Bertoni A.G.
        • Szklo M.
        • Folsom A.R.
        Serological evidence of infections and Type 2 diabetes: the MultiEthnic Study of Atherosclerosis.
        Diab Med: J Br Diab Assoc. 2009; 26: 149-152
        • Xu C.
        • Yan M.
        • Sun Y.
        • Joo J.
        • Wan X.
        • Yu C.
        • et al.
        Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population.
        Helicobacter. 2014; 19: 437-442
        • de Luis D.A.
        • Garcia Avello A.
        • Lasuncion M.A.
        • Aller R.
        • Martin de Argila C.
        • Boixeda de Miquel D.
        • et al.
        Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients.
        Clin Nutr. 1999; 18: 227-231
        • Horikawa C.
        • Kodama S.
        • Fujihara K.
        • Yachi Y.
        • Tanaka S.
        • Suzuki A.
        • et al.
        Association of Helicobacter pylori infection with glycemic control in patients with diabetes: a meta-analysis.
        J Diab Res. 2014; : 250620
        • Chen Y.
        • Blaser M.J.
        Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels.
        J Infect Dis. 2012; 205: 1195-1202
        • Aydogan T.
        • Ulas T.
        • Selcoki Y.
        • Alkan R.
        • Yılmaz O.C.
        • Yalcın K.S.
        • et al.
        The effects of Helicobacter pylori eradication on proteinuria in patients with primary glomerulonephritis.
        Wien Klin Wochenschr. 2012; 124: 241-244
        • Oshima T.
        • Ozono R.
        • Yano Y.
        • Oishi Y.
        • Teragawa H.
        • Higashi Y.
        • et al.
        Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects.
        J Am Coll Cardiol. 2005; 45: 1219-1222
        • He C.
        • Yang Z.
        • Lu N.H.
        Helicobacter pylori infection and diabetes: is it a myth or fact?.
        World J Gastroenterol. 2014; 20: 4607-4617
        • Talebi-Taher M.
        • Mashayekhi M.
        • Hashemi M.H.
        • Bahrani V.
        Helicobacter pylori in diabetic and non-diabetic patients with dyspepsia.
        Acta Med Iran. 2012; 50: 315-318
        • Xia H.H.
        • Talley N.J.
        • Kam E.P.
        • Young L.J.
        • Hammer J.
        • Horowitz M.
        Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus.
        Am J Gastroenterol. 2001; 96: 1039-1046
        • Devrajani B.R.
        • Shah S.Z.
        • Soomro A.A.
        • Devrajani T.
        Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case–control study.
        Int J Diab Dev Ctries. 2010; 30: 22-26
        • Chung G.E.
        • Heo N.J.
        • Park M.J.
        • Chung S.J.
        • Kang H.Y.
        • Kang S.J.
        Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria.
        World J Gastroenterol. 2013; 19: 97-102
        • Wang F.
        • Fu Y.
        • Lv Z.
        Association of Helicobacter pylori infection with diabetic complications: a meta-analysis.
        Endocr Res. 2014; 39: 7-12
        • Levey A.S.
        • Eckardt K.U.
        • Tsukamoto Y.
        • et al.
        Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
        Kidney Int. 2005; 67: 2089-2100
        • Simon L.
        • Tornoczky J.
        • Toth M.
        • Jambor M.
        • Sudar Z.
        The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice.
        Orvosi Hetilap. 1989; 130: 1325-1329
        • Caramori M.L.
        • Fioretto P.
        • Mauer M.
        The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?.
        Diabetes. 2000; 49: 1399-1408
        • Lim A.
        Diabetic nephropathy – complications and treatment.
        Int J Nephrol Renovasc Dis. 2014; 7: 361-381
        • Lo M.K.
        • Lee K.F.
        • Chan N.N.
        • Leung W.Y.
        • Ko G.T.
        • Chan W.B.
        • et al.
        Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
        Diabetes Obes Metab. 2004; 6: 223-230
        • Wang F.
        • Liu J.
        • Lv Z.
        Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a meta-analysis of 39 studies involving more than 20,000 participants.
        Scand J Infect Dis. 2013; 45: 930-938
        • Hamed S.A.
        • Amine N.F.
        • Galal G.M.
        • Helal S.R.
        • Tag El-Din L.M.
        • Shawky O.A.
        • et al.
        Vascular risks and complications in diabetes mellitus: the role of Helicobacter pylori infection.
        J Stroke Cerebrovasc Dis: Offi J Natl Stroke Assoc. 2008; 17: 86-94
        • de Luis D.A.
        • Lahera M.
        • Canton R.
        • Boixeda D.
        • San Roman A.L.
        • Aller R.
        • et al.
        Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients.
        Diabetes Care. 1998; 21: 1129-1132
        • Agrawal R.P.
        • Sharma R.
        • Garg D.
        • Pokharna R.
        • Kochar D.K.
        • Kothari R.P.
        Role of Helicobacter pylori in causation of diabetic gastropathies and non-gastrointestinal complications in type 2 diabetes.
        J Indian Med Assoc. 2010; 108: 140-143
        • Gentile S.
        • Turco S.
        • Oliviero B.
        • Torella R.
        The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus.
        Diabetes Res Clin Pract. 1998; 42: 41-48
        • Gulcelik N.E.
        • Kaya E.
        • Demirbas B.
        • Culha C.
        • Koc G.
        • Ozkaya M.
        • et al.
        Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy.
        J Endocrinol Investig. 2005; 28: 214-217
        • Anastasios R.
        • Goritsas C.
        • Papamihail C.
        • Trigidou R.
        • Garzonis P.
        • Ferti A.
        Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings.
        Eur J Intern Med. 2002; 13: 376
        • Tanriverdi O.
        Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients.
        Turk J Gastroenterol: Offi J Turk Soc Gastroenterol. 2011; 22: 569-574
        • Ishida Y.
        • Suzuki K.
        • Taki K.
        • Niwa T.
        • Kurotsuchi S.
        • Ando H.
        • et al.
        Significant association between Helicobacter pylori infection and serum C-reactive protein.
        Int J Med Sci. 2008; 5: 224-229
        • Navarro J.F.
        • Mora C.
        • Muros M.
        • Garcia J.
        Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
        Nephrol Dial Transplant. 2006; 21: 3428-3434